BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24222525)

  • 21. Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts.
    Orlova VV; Drabsch Y; Freund C; Petrus-Reurer S; van den Hil FE; Muenthaisong S; Dijke PT; Mummery CL
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):177-86. PubMed ID: 24158517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-angiogenic activity of Ipomoea obscura extract and Ipobscurine-A.
    Hamsa TP; Kuttan G
    Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):488-97. PubMed ID: 21058930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-angiogenic activities of nucleosides and nucleotides and their structure-activity relationship.
    Tsukamoto I; Konishi R; Kubota Y; Tokuda M; Sakakibara N; Maruyama T
    Nucleic Acids Symp Ser (Oxf); 2007; (51):437-8. PubMed ID: 18029774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulation.
    Radi M; Evensen L; Dreassi E; Zamperini C; Caporicci M; Falchi F; Musumeci F; Schenone S; Lorens JB; Botta M
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5579-83. PubMed ID: 22853993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-silico fragment-based identification of novel angiogenesis inhibitors.
    Dakshanamurthy S; Kim M; Brown ML; Byers SW
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4551-6. PubMed ID: 17591441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nobiletin, a polymethoxylated flavonoid from citrus, shows anti-angiogenic activity in a zebrafish in vivo model and HUVEC in vitro model.
    Lam KH; Alex D; Lam IK; Tsui SK; Yang ZF; Lee SM
    J Cell Biochem; 2011 Nov; 112(11):3313-21. PubMed ID: 21748787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
    Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
    J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lycopene and apigenin on human umbilical vein endothelial cells in vitro under angiogenic stimulation.
    Sahin M; Sahin E; Gümüşlü S
    Acta Histochem; 2012 Feb; 114(2):94-100. PubMed ID: 21474164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment.
    Seng WL; Eng K; Lee J; McGrath P
    Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, in vitro and in vivo preliminary evaluation of anti-angiogenic properties of some pyrroloazaflavones.
    Ferlin MG; Conconi MT; Urbani L; Oselladore B; Guidolin D; Di Liddo R; Parnigotto PP
    Bioorg Med Chem; 2011 Jan; 19(1):448-57. PubMed ID: 21145750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma.
    Sun CC; Zhang YS; Xue X; Cheng YN; Liu HP; Zhao CR; Lou HX; Qu XJ
    Eur J Pharmacol; 2011 Sep; 667(1-3):136-43. PubMed ID: 21704029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.
    Hussain S; Slevin M; Matou S; Ahmed N; Choudhary MI; Ranjit R; West D; Gaffney J
    Angiogenesis; 2008; 11(3):245-56. PubMed ID: 18330714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The microtubule depolymerizing agent CYT997 causes extensive ablation of tumor vasculature in vivo.
    Burns CJ; Fantino E; Powell AK; Shnyder SD; Cooper PA; Nelson S; Christophi C; Malcontenti-Wilson C; Dubljevic V; Harte MF; Joffe M; Phillips ID; Segal D; Wilks AF; Smith GD
    J Pharmacol Exp Ther; 2011 Dec; 339(3):799-806. PubMed ID: 21917561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
    La DS; Belzile J; Bready JV; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn JC; Flynn SR; Graceffa RF; Harriman SP; Larrow JF; Long AM; Martin MW; Morrison MJ; Patel VF; Roveto PM; Wang L; Weiss MM; Whittington DA; Teffera Y; Zhao Z; Polverino AJ; Harmange JC
    J Med Chem; 2008 Mar; 51(6):1695-705. PubMed ID: 18311900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of 4-amino-2-(thio)phenol derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: synthesis and biological evaluation. Part II.
    Xu F; Zhang L; Jia Y; Wang X; Li X; Wen Q; Zhang Y; Xu W
    Eur J Med Chem; 2013 Nov; 69():191-200. PubMed ID: 24036042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationships of N-methyl-5,6,7-trimethoxylindoles as novel antimitotic and vascular disrupting agents.
    Zhao DG; Chen J; Du YR; Ma YY; Chen YX; Gao K; Hu BR
    J Med Chem; 2013 Feb; 56(4):1467-77. PubMed ID: 23360369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab.
    Jouan-Hureaux V; Boura C; Merlin JL; Faivre B
    Microvasc Res; 2012 Mar; 83(2):131-7. PubMed ID: 21820450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Punarnavine, an alkaloid from Boerhaavia diffusa exhibits anti-angiogenic activity via downregulation of VEGF in vitro and in vivo.
    Saraswati S; Alhaider AA; Agrawal SS
    Chem Biol Interact; 2013 Nov; 206(2):204-13. PubMed ID: 24060680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of nicotinamide derivative as anti-angiogenic agents.
    Choi HE; Choi JH; Lee JY; Kim JH; Kim JH; Lee JK; Kim GI; Park Y; Chi YH; Paik SH; Lee JH; Lee KT
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2083-8. PubMed ID: 23453071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.